Provide feedbackProvide feedback

« Back

MDxHealth signs agreement with Prime Health Services to provide greater access to prostate cancer test

Tuesday, March 04 2014 | Comments
Evidence Grade 0 What's This?
MDxHealth SA, a Belgian molecular diagnostic company, signed an agreement with Prime Health Services Inc., a national medical cost-containment company that includes a preferred provider organization network, to offer patients greater access to MDxHealth's ConfirmMDx for prostate cancer test.

The agreement will extend the access to the test to Prime Health's 144 million members in all 50 states.

According to MDxHealth, its test reduces the number of false negative prostate biopsy results, which are seen in approximately 25 percent to 35 percent of the nearly 1 million men with a negative prostate cancer biopsy each year.

The company said agreements such this one will shorten its reimbursement cycle and increase revenue for this year.

Print  |  E-mail

Comments

Be the first to write a comment for this article!

You must be logged in to post a comment.